Alaunos Therapeutics, Inc. (TCRT) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TCRT Revenue Growth
TCRT Revenue Analysis (2013–2024)
As of May 8, 2026, Alaunos Therapeutics, Inc. (TCRT) generated trailing twelve-month (TTM) revenue of $6,000. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, TCRT's historical revenue data shows a 3-year CAGR of -70.7%. The company achieved its highest annual revenue of $6.9 million in 2016.
When compared to Healthcare sector peers including IOVA (+34.3% YoY), FATE (-51.2% YoY), and TCRX (+84.4% YoY). Compare TCRT vs IOVA →
TCRT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TCRTCurrent | $6,000 | - | - | -48120.0% | |
 IOVA | $264M | +34.3% | - | -153.1% | |
 FATE | $7M | -51.2% | -26.7% | -2222.4% | |
 TCRX | $10M | +84.4% | +56.9% | -1315.4% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% |
TCRT Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $10K | +100.0% | $10K | 100.0% | $-4,812,000 | -48120.0% |
| 2023 | $5K | -99.8% | $-4,798,000 | -95960.0% | $-34,267,000 | -685340.0% |
| 2022 | $2.9M | +634.2% | $2.9M | 100.0% | $-35,105,000 | -1201.4% |
| 2021 | $398K | - | $398K | 100.0% | $-77,549,000 | -19484.7% |
| 2020 | $0 | - | $-1,128,000 | - | $-80,361,000 | - |
| 2019 | $0 | -100.0% | $-629,000 | - | $-57,858,000 | - |
| 2018 | $146K | -97.7% | $146K | 100.0% | $-53,906,000 | -36921.9% |
| 2017 | $6.4M | -6.9% | $6.4M | 100.0% | $-53,493,000 | -837.3% |
| 2016 | $6.9M | +58.4% | $6.9M | 100.0% | $-165,307,000 | -2409.4% |
| 2015 | $4.3M | +215.5% | $4.3M | 100.0% | $-120,100,000 | -2772.4% |
See TCRT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TCRT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TCRT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTCRT — Frequently Asked Questions
Quick answers to the most common questions about buying TCRT stock.
Is TCRT's revenue growth accelerating or slowing?
TCRT TTM revenue: $6000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TCRT's long-term revenue growth rate?
Alaunos Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is TCRT's revenue distributed by segment?
TCRT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.